You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A new assay uses digital loop-mediated isothermal amplification (dLAMP) to perform phenotypic antibacterial susceptibility testing in 30 minutes.
The firm, which started in immunodiagnostics, is constructing a new building to house its molecular biology business.
The approach is based on a new approval of the BacT/ALERT Virtuo system and new indications for the firm's procalcitonin assay.
The firm recently presented data on its first two products that use its proprietary 3Base technology.
The company was founded earlier this year based on an improved method for multiple displacement amplification and a single-cell-variant caller.
The test was approved for lab use, but it runs on a platform with the potential for point-of-care applications.
The Dutch firm expects its product to be the first commercial test on the market to diagnose IBD by analyzing a patient's gut microbiome.
The technology has been a core capability of the firm, which is expanding its suite of products to address the broader needs of genomics researchers.
The Bay Area firm is planning to launch a low-cost, microfluidics-based infectious disease diagnostic called the Simple Chip in the next few years.
The method uses graphene-coated silica particles fused to complementary RNA to register impedance changes in the presence of viruses.
The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.
Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.
The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.
In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.